Netflix NFLX stock has upside – Buy The Dips on NFLX stock & here is why

Physicians Flock to Bluesky, Hoping to Leave X Behind

In the wake of the presidential election, physicians have been flocking to the social media platform Bluesky, asserting there’s now a critical mass of medical

November 20, 2024

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics.

March 11, 2024

Coeptis licenses Deverra Therapeutics’ clinical stage assets

DVX201 is being assessed in a Phase I clinical study for treating haematologic malignancies and viral infections. Credit: Kateryna Kon/Shutterstock.com. Coeptis Therapeutics has exclusively licensed

August 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.